Sandoz shipped pantoprazole sodium, an injectable drug used to treat adults with astroesophageal reflux disease as well as pathological hypersecretion conditions, including Zollinger-Ellison syndrome.
Sandoz and Civica Rx entered into a five-year agreement in July for Sandoz to supply it with drugs that are commonly in shortage in U.S. hospitals. Civica Rx is a nonprofit organization fighting drug shortages.
Sandoz had said it plans to supply six injectable drugs to Civica Rx, but announced Nov. 2 that it will add a drug used to regulate blood pressure, which has been frequently used to treat COVID-19 patients.
Read the full news release here.
More articles on pharmacy:
FDA reviewers appear to endorse Biogen’s Alzheimer’s drug
Americans have almost doubled spending on specialty drugs from pharmacies, study finds
FDA, FTC warn 2 companies selling faulty COVID-19 treatments
